9 Meters Biopharma, Inc. MNTRQ

Market cap
$1.0M
P/E
0.0×
Mar '23 Dec '22 Sep '22 Jun '22 Older periods
ROE
(375.64%) (198.92%) (131.96%) (112.23%)

+8 more TTM periods

ROA
(190.56%) (105.05%) (83.78%) (93.49%)
ROIC
0.00% 0.00% (159.04%) 0.00%
Return on Tangible Assets
726.46% (1,876.45%) (738.63%) (206.95%)
Average Days of Receivables
— — — —
Free Cash Flow per Share
(2.74) (2.87) (2.74) (2.60)
Free Cash Flow
(37.24) (37.25) (35.48) (33.69)
Capital Expenditures
— 0.00 (0.01) (0.01)
Piotroski F-Score
1.00 1.00 2.00 1.00
Other line items
Cash ROIC
(573.52%) (71.91%) (74.26%) (65.17%)
Accounts Payable Turnover
0.00 0.00 0.01 0.00
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
188,331.10 216,986.06 58,961.85 98,719.77
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.80 0.85 0.86 0.74
Depreciation/Fixed assets
265.79 176.93 39.18 0.60
Capex/Depreciation
0.00 0.00 (0.01) (0.97)
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(2.74) (2.87) (2.74) (2.60)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
— 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates